Company: TELO
Filing Date: 2025-11-28
Form Type: PRER14A
Source: 0001493152-25-025406
Chunk: 175

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-28
Form: PRER14A
Chunk 175
---
 be expected to have a Material Adverse Effect on TELI;

6.3.1 each of the covenants and obligations of TELI to be performed at or before the Effective Time pursuant to the terms of this Agreement, including, without limitation, the covenants set forth in Section 5.2, shall have been duly performed in all material respects at or before the Effective Time;

6.3.2 TELI shall not have suffered a Material Adverse Effect after the date hereof; and

6.3.3 Certain major shareholders of TELI (including Bayshore Trust and related parties, the “ Contributing Shareholders”) shall have committed to contribute to Company assets and/or cash (or any combination thereof) totaling $5,000,000 (the “ Cash Contribution”), with $1,000,000 due at Closing, $2,000,000 due upon acceptance by the U.S. Food and Drug Administration (“ FDA”) of the applicable Investigational New Drug application (“ IND”), and $2,000,000 due upon initiation of Phase 1 or 2 clinical trial. In the event any milestone contribution is not funded within three (3) months of the applicable milestone date, the corresponding shares shall be automatically canceled and permanently revert to the Company’s treasury, without adjustment to the exchange ratio or other terms of the Agreement.

<div align='center'>Article VII Termination</div>

7.1 Termination. Notwithstanding anything to the contrary in this Agreement, this Agreement may be terminated and the Merger may be abandoned at any time prior to the Effective Time:

7.1.0 By mutual written consent of the Company and TELI;

7.1.1 By either the Company or TELI, upon delivery of written notice to the other, if the Closing shall not have occurred on or before December 31, 2025 (the “ Termination Date”); provided, however, that neither the Company nor TELI will be entitled to terminate this Agreement under this Section ‎7.1.1if such Person’s material breach of or material failure to fulfill any obligation under this Agreement has been the cause of, or resulted in, the failure of the Closing to occur on or before the Termination Date;

7.1.2 By either the Company or TELI, upon written notice to the other, if a Governmental Entity having competent jurisdiction shall have issued or entered any Order or taken any action, or enacted any Applicable Law, which,